Identification |
Name: | Propanoic acid,2,2-dimethyl-,4-[[[2-[[(carboxymethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester,sodium salt (1:1) |
Synonyms: | Glycine,N-[2-[[[4-(2,2-dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-,monosodium salt (9CI);ONO 5046-Na;Sivelestat sodium;Sodium sivelestat; |
CAS: | 150374-95-1 |
Molecular Formula: | C20H21N2NaO7S |
Molecular Weight: | 456.44 |
InChI: | InChI=1/C20H22N2O7S.Na/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24;/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24);/q;+1/p-1 |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | g/cm3 |
Biological Activity: | Selective leukocyte elastase inhibitor (IC 50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF- κ B activation and LTB 4 -induced neutrophil transmigration in vitro . Significantly attenuates ischemia-induced spinal cord injury, decreases serum cytokine levels and reduces acute inflammatory lung injury in vivo . |
Flash Point: | °C |
Safety Data |
|
|